If innovative cancer therapies were the top launches to watch in 2024, this year’s high-profile biopharma debuts is slated to ...
Blockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) lead Evaluate Pharma’s list of ...
Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...
In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...
The price of Zepbound vials is less than the list price of the normal packages ... to people without insurance coverage for the drugs. "Lilly's release of Zepbound single-dose vials at a lower ...
The Washington Post on MSN10d
FDA approves weight-loss drug Zepbound to treat sleep apneaThe Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Eli Lilly's shortage of diabetes and obesity drugs is over, halting competition with knock-offs In October, when the FDA initially erased tirzepatide from its shortage list, a compounding industry ...
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback